76.51 USD
↘ 1.57 (2.01%)AT CLOSE (11:59 AM EDT)
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
KNSANASDAQ • USD
77.79
↗ 1.28 (1.67%)
POST MARKET (AS OF 07:51 PM EDT)
Post Market
AS OF 07:51 PM EDT
77.79
↗ 1.28 (1.67%)
Market: CLOSED
Shares of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) are trading at $76.49. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. Notable factors include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 6, 2026.
Open?$77.88
High?$78.80
Low?$75.74
Prev. Close?$78.08
Volume?353.3K
Avg. Volume?995.1K
VWAP?$76.53
Rel. Volume?0.36x
Bid / Ask
Bid?$75.21 × 100
Ask?$81.00 × 1.0K
Spread?$5.79
Midpoint?$78.10
Valuation & Ratios
Market Cap?6.0B
Shares Out?48.3M
Float?38.9M
Float %?84.2%
P/E Ratio?81.71
P/B Ratio?9.86
EPS?$0.94
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Address
105 PICCADILLY, SECOND FLOOR
LONDON, W1J 7NJ
Phone: (781) 431-9100
LONDON, W1J 7NJ
Phone: (781) 431-9100
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?87
Short Sent.?29
Piotroski F-Score?5/9Mixed
Altman Z-Score?17.49Safe
Confidence?59%Low
Short InterestHigh
Short % of Float?11.59%High
Short Interest?4.5M
Days to Cover?6.9
Free Float38.9M
Avg Daily Volume658.5K
Settlement Date2026-07-15
Financial Health
Current Ratio?3.79Strong
Quick Ratio?3.33Strong
Cash Ratio?1.21Strong
Debt/Equity?0.12Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score33/100
P/E?81.7PRICEY▾
Peers100
S&P3
P/B?9.86HIGH▾
Peers100
S&P19
P/S?7.92HIGH▾
Peers100
S&P13
P/FCF?36.4PRICEY▾
Peers100
S&P20
EV/EBITDA?61.7HIGH▾
Peers100
S&P3
EV/Sales?7.77HIGH▾
Peers100
S&P17
Returns & Efficiency
ROE?12.1%STRONG▾
Peers50
S&P43
ROA?8.9%STRONG▾
Peers50
S&P70
Cash Flow & Enterprise
FCF?$164.2M
Enterprise Value?$5.9B
Fundamentals ratios updated end of day